Cellectar Biosciences, Inc. — Director's Dealing 2020

Jun 8, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cellectar Biosciences, Inc. (CLRB)
CIK: 0001279704
Period of Report: 2020-06-04

Reporting Person: HILL STEPHEN A (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-06-04	Common Stock	P	18000	$1.0799	Acquired	18000	Direct